HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Industry Seeks Options As States Put Pseudoephedrine Behind The Counter

This article was originally published in The Tan Sheet

Executive Summary

Passage of laws in Iowa and Kentucky restricting pseudoephedrine to behind-the-counter sale follows a similar methamphetamine precursor control bill in Arkansas

You may also be interested in...



Pseudoephedrine Behind-The-Counter Limits Loom In Patchwork Of State Bills

The U.S. Attorney General would be required to report to Congress on the effectiveness of state efforts to prevent methamphetamine precursor diversion under a House bill introduced March 2

Pseudoephedrine Behind-The-Counter Limit Sought By Meth Fighting Senators

A bipartisan bill limiting pseudoephedrine-containing products to behind-the-counter sale nationwide reflects increased support for the strategy in the 109th Congress

Leiner Expands OTC Portfolio With Phenylephrine HCl, Ibuprofen Offerings

Leiner plans to launch phenylephrine HCl 10 mg - a "next option" nasal decongestant - in early 2005 to reach an untapped market, the firm announced at the PLMA trade show in Chicago Nov. 14-16

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS126424

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel